Back to search

Article

Erenumab in highly therapy-refractory migraine patients First German Real-world evidence

2020-06-17

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Calcitonin gene related peptide (CGRP) monoclonal antibodies (mAB) are the first specific migraine prophylactic medication. Erenumab is the only CGRP mAB targeting the CGRP receptor. Clinical data regarding efficacy and tolerability of erenumab in highly therapy-refractory patients are not available, yet, although many patients treated with CGRP mAB under real w...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
700ff757-c0b2-5e25-bcc5-3abd2978e90a
DOI
10.21203/rs.3.rs-19814/v4
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Erenumab in highly therapy-refractory migraine patients First German Real-world evidenceDOI 10.21203/rs.3.rs-19814/v4
Real-world Evidence Data on the Monoclonal Antibody Erenumab in Migraine Prevention: Perspectives of Treating Physicians in GermanySemantic proximity
Real-world experience of erenumab in patients with chronic or episodic migraine in the UAESemantic proximity
Efficacy and Safety of CGRP Monoclonal Antibodies for the Prevention of Migraine Compared with Placebo: A Systematic Review and Meta-AnalysisSemantic proximity
Different Doses of Erenumab for Preventive Treatment of Episodic Migraine: A Systematic Review and Network Meta-AnalysisSemantic proximity
Unveiling the Efficacy and Safety of Erenumab, a Monoclonal Antibody Targeting Calcitonin Gene-related Peptide (CGRP) Receptor, in Patients with Chronic and Episodic Migraine: A GRADE-assessed Systematic Review and Meta-analysis of Randomized Clinical Trials with Subgroup AnalysisSemantic proximity
Efficacy of fremanezumab in refractory chronic migraine patients: Real-world data from the Hull Migraine Clinic, UKSemantic proximity
Monoclonal Antibodies Against Calcitonin Gene-related Peptide for Migraine Prophylaxis: A Systematic Review of Real-world DataSemantic proximity
Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine – An updated systematic review and meta-analysisSemantic proximity
Safety efficacy and tolerability of the calcitonin gene-related peptide monoclonal antibodies for migraine prevention in a real world settingSemantic proximity
Cgrp Monoclonal Antibodies: Key Lessons from Real World EvidenceSemantic proximity
An Investigation into the Prevalence of Migraine and its Prophylactic Treatment Patterns in the Czech RepublicSemantic proximity
Psychological Predictors of Negative Treatment Outcome with Erenumab in Chronic Migraine: Data From an Open Label Long-Term Prospective StudySemantic proximity
Select a neighboring publication to make it the new centre.